… Prostate cancer (PCa) has traditionally been diagnosed by digital rectal examination (DRE)
and prostate-specific antigen (PSA) blood test, followed by transrectal ultrasound (TRUS) …

… risk of developing prostate cancer, and for whom repeat prostate biopsies are mandatory. …
of prostate cancer diagnosis, prostate-cancer-specific markers, such as prostate cancer gene 3 …

… rate of prostate cancer in general and that of clinically insignificant prostate cancers in
particular: the … 5, clinical suspicion of prostate cancer is raised usually by abnormal digital rectal …

… risk of a diagnosis of prostate cancer is now about 16 percent, whereas the lifetime risk of
death from prostate cancer is about 3.4 percent. Obviously, most prostate cancers that are …

… Importance Prostate cancer is the most common cancer diagnosis made in men with more
than … advances in prostate cancer diagnosis and treatment. Screening for prostate cancer has …

… prostate cancer detection narrow the gap between the incidence and true prevalence of
prostate cancer… This, however, raises concerns about the risk of over detection of latent cancers …

… Prostate cancer is the most common cancer in men in many western countries, and the second
leading cause of cancer … of men undergoing biopsies for the diagnosis of prostate cancer. …

Prostate cancer (PCa) is the second most common cancer in men worldwide. A large
proportion of PCa are latent, never destined to progress or affect the patients’ life. It is of utmost …

… of over and under diagnosis of prostate cancer in 2 … diagnosis (0.5 cm 3 or less, confined
to the prostate with clear surgical margins and no Gleason pattern 4 or 5) and under diagnosis (…

Purpose Older men are more likely to be diagnosed with high-risk prostate cancer and to have
lower overall survival. As a result, age often plays a role in treatment choice. However, the …